Feel Better / Function Optimally with Integrative Medicine & Manual Therapy
In Integrative Manual Therapy allergies are associated with six areas of the body and how these areas communicate with the immune system and the detoxification system. These areas include the Hilum of Kidneys, Cavernous Sinuses, Sigmoid Colon / Rectum, Lungs, Hands, and Face. There are specific motilities that are thought to be manifestations of allergies which can be felt in each of these areas. The treatment for the aberrant motilities is Resistance Therapy. - Sharon W. Giammatteo, PT, PhD
This issue of The Burnham Review looks at Anaphylaxis, Allergies, Plants, Food, and improved function of areas associated with allergies, thereby decreasing signs and symptoms...............Buy This Issue TodayBack Issues Available for $6 each or
Any 6 issues for $25
Subscriptions Available Today
for $100 per year (24 Information Packed Issues)
Go To The Shopping Cart Now
Look For These Back Issues
7-1 Benefits of Touch and NFP, The Burnham Review FREE Today
7-2 Integrative Manual Therapy (IMT) Where Is It Written?, The Burnham Review FREE Today
7-3 A Nutritional Wellness Self Study Program, The Burnham Review
7-4 NeuroAnatomy Study List for Manual Therapists, The Burnham Review
7-5 Manual Therapy and the Peace Process, The Burnham Review
4-23 Nut Allergies and Chinese Herbs, The Burnham Review
6-23 Gluten Sensitivity and Celiacs, The Burnham Review
8-24 Consciousness, The Burnham Review
Therapeutic Strategies for Peanut Allergies and Asthma Summarizing The Components of Peanuts
"Among the therapeutic strategies reviewed are sublingual and oral immunotherapy, anti-IgE, Chinese herbal medicine, and vaccine strategies."1 (Sicherer,2007).
The formula was labeled ASHMI (for Antiasthma Herbal Medicine Intervention Formula) and produced by Weifeng Pharmaceutical Factory in China. For a daily dosage, 32 grams of raw herbs were concentrated down to 3.6 grams, and given in 12 capsules. The following three herbs were used:
(1) Ling zhi (ganoderma lucidum) 20 g, has immune-enhancing effects, and at this dosage, one can accept that the cytokine levels moved towards normalization.
(2) Ku shen (radix sophorae flavascentis), 9 g, reduces heat in the lung (in addition to its strong antimicrobial effects), which could prove important in relaxing bronchial spasm. Most asthma is thought, both in TCM and Western medicine, to be the consequence of allergic inflammation, and the cooling properties of ku shen reduce that.
(3) The use of a small amount of gan cao (radix glycerrhizae), 3 g helps to harmonize ling zhi with ku shen. (Fratkin,2005), (Decision News,2005), (Wen,2005), and (Srivastava,2005).
Peanuts have 5 identified Bowman-Birk type protease inhibitors. Bowman-Birk Inhibitors (BBI) are natural insecticides. Used therapeutically they are also radio-protective (protective against radiation) of normal fibroblasts by improving nucleotide excision repair mechanisms and at the same time being used as sensitizing agents for cancer related radiation and chemotherapy.
Peanuts have 8 Ara h allergens, which cause agglutination with a number of different tumor tissues as well as normal tissues. These are IgE allergens, which activate the T-Helper cells (Th2) and T-Lymphocytes (CD4 subset). These contribute to an inflammatory effect and anaphylaxis. These allergens are also resistant to proteolytic enzymes (protease inhibitors) and heat resistant.
Resveratrol is another component of peanuts. It is an antioxidant which is anti-inflammatory and cardio-protective.
It is interesting to note that one of the components of the Chinese herbal formula for decreasing the severity of peanut allergies is Ganoderma lucidum. Water soluble extracts from this fungus are also radio-protective.
Highlighted References
Public Medline [PubMed Abstract] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14641608
General References
1. Sampson, H. A. (2000). "Food anaphylaxis." Br Med Bull 56(4): 925-35. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11359629
2. Avery, N. J., R. M. King, et al. (2003). "Assessment of quality of life in children with peanut allergy." Pediatr Allergy Immunol 14(5): 378-82. [PubMed Abstract]
3.de Leon, M. P., J. M. Rolland, et al. (2007). "The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy." Expert Rev Mol Med 9(1): 1-18. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17210088 and http://journals.cambridge.org/download.php?file=%2FERM%2FERM9_01%2FS1462399407000208a.pdf&code=ad9b383ed3cd44f8589a28152cc6112a
4.de Leon, M. P., J. M. Rolland, et al. (2007). "The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy." Expert Rev Mol Med 9(1): 1-18. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17210088 and http://journals.cambridge.org/download.php?file=%2FERM%2FERM9_01%2FS1462399407000208a.pdf&code=ad9b383ed3cd44f8589a28152cc6112a
5. Palmer, K. and W. Burks (2006). "Current developments in peanut allergy." Curr Opin Allergy Clin Immunol 6(3): 202-6. [PubMed Abstract]
6.de Leon, M. P., J. M. Rolland, et al. (2007). "The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy." Expert Rev Mol Med 9(1): 1-18. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17210088 and http://journals.cambridge.org/download.php?file=%2FERM%2FERM9_01%2FS1462399407000208a.pdf&code=ad9b383ed3cd44f8589a28152cc6112a
7. de Leon, M. P., A. C. Drew, et al. (2005). "Functional analysis of cross-reactive immunoglobulin E antibodies: peanut-specific immunoglobulin E sensitizes basophils to tree nut allergens." Clin Exp Allergy 35(8): 1056-64. [PubMed Abstract]
8.de Leon, M. P., J. M. Rolland, et al. (2007). "The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy." Expert Rev Mol Med 9(1): 1-18. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17210088
9.de Leon, M. P., J. M. Rolland, et al. (2007). "The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy." Expert Rev Mol Med 9(1): 1-18. [Full Text]
10. US Department of Agriculture [Full Text] http://plants.usda.gov/.
11. The International Union of Immunological Societies Allergen (IUIS) Nomenclature Sub-committee website provides the official list of allergens [Full Text] http://www.allergen.org
12. The Allergome website contains information and relevant publications of allergens that are officially recognized by the IUIS Allergen Nomenclature Sub-committee [Full Text] http://www.allergome.org
13.de Leon, M. P., J. M. Rolland, et al. (2007). "The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy." Expert Rev Mol Med 9(1): 1-18. [Full Text]
14.de Leon, M. P., J. M. Rolland, et al. (2007). "The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy." Expert Rev Mol Med 9(1): 1-18. [Full Text]
15. Sheffer, A. L. (2004). "Anaphylaxis: clinical aspects." Allergy Asthma Proc 25(1): 31-2. [PubMed Abstract]
16. Windbichler, M., B. Echtenacher, et al. (2006). "Investigations on the involvement of the lectin pathway of complement activation in anaphylaxis." Int Arch Allergy Immunol 141(1): 11- 23.[PubMed Abstract]
17. Brand, P. L. (2007). "[Anaphylaxis: facts and fallacies]." Ned Tijdschr Geneeskd 151(10): 574-7.
18. Hourihane, J. O. (1997). "Peanut allergy: recent advances and unresolved issues." J R Soc Med 90 Suppl 30: 40-4. [Full Text] http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1296084
19. Hourihane, J. O. (1997). "Peanut allergy: recent advances and unresolved issues." J R Soc Med 90 Suppl 30: 40-4. [Full Text]
20. Lehmann, K., K. Schweimer, et al. (2006). "Structure and stability of 2S albumin-type peanut allergens: implications for the severity of peanut allergic reactions." Biochem J 395(3): 463-72. [Full Text] http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16372900
21. Peeters, K. A., S. J. Koppelman, et al. (2007). "Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy?" Clin Exp Allergy 37(1): 108-15. [PubMed Abstract]
22. Sicherer, S. H., A. Munoz-Furlong, et al. (2003). "Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study." J Allergy Clin Immunol 112(6): 1203-7. [PubMed Abstract] 23. Sicherer, S. H. and H. A. Sampson (2007). "Peanut allergy: emerging concepts and approaches for an apparent epidemic." J Allergy Clin Immunol 120(3): 491-503; quiz 504-5. [PubMed Abstract] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17689596
24. Egal, S., A. Hounsa, et al. (2005). "Dietary exposure to aflatoxin from maize and groundnut in young children from Benin and Togo, West Africa." Int J Food Microbiol 104(2): 215-24. [PubMed Abstract] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15979184
25. Flinterman, A. E., E. van Hoffen, et al. (2007). "Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time." Clin Exp Allergy 37(8): 1221- 8. [PubMed Abstract] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17651153
26. Berger, W. E. (2001). "Anti-IgE Therapy: A revolutionary approach to controlling allergy and asthma." Allergy & Asthma Health, Spring 2001 and The MA Report, May 2004 Incorporating Omalizumab into Asthma Treatment Guidelines: Consensus Panel Recommendations . www.ptcommunity.com/ptjournal/fulltext/28/6/PTJ2806400.pdf: [Full Text] http://www.aanma.org/pharmacy/ph_med_anti_ige.htm .
27. Yu, J. W., R. Kagan, et al. (2006). "Accidental ingestions in children with peanut allergy." J Allergy Clin Immunol 118(2): 466-72. [PubMed Abstract]
28. Sicherer, S. H. and H. A. Sampson (2007). "Peanut allergy: emerging concepts and approaches for an apparent epidemic." J Allergy Clin Immunol 120(3): 491-503; quiz 504-5. [PubMed Abstract]
29. Qu, C., K. Srivastava, et al. (2007). "Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferongamma." Clin Exp Allergy 37(6): 846-55. [PubMed Abstract]
30. Srivastava, K. D., J. D. Kattan, et al. (2005). "The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy."
J Allergy Clin Immunol 115(1): 171-8. [Abstract] http://www.ihopnet.org/UniPub/iHOP/pm/11100767.html?pmid=15637565 and [Abstract] https://asthmacasestudies.org/media/jaci/2005/01/herbal.stm and [Abstract] http://grande.nal.usda.gov/ibids/index.php?mode2=detail&origin=ibids_references&therow=763366
31. Fratkin, J. P. (2005). "Stunning Herbal Formula Wins Recognition in the Western Medical Community." Acupuncture Today 06(12): [Full Text] http://www.acupuncturetoday.com/archives2005/dec/12fratkin.html
32. Decision News Media. www.nutraingredients-usa.com/news/ng.asp?n=63278-chinesemedicine-asthma-ephedrine
33. Wen MC, Wei CH, Hu ZQ, et al. Efficacy and tolerability of antiasthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol, September 2005.
34. Srivastava, K. D., J. D. Kattan, et al. (2005). "The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy." J Allergy Clin Immunol 115(1): 171-8. [Abstract] http://www.ihopnet.org/UniPub/iHOP/pm/11100767.html?pmid=15637565 and [Abstract] https://asthmacasestudies.org/media/jaci/2005/01/herbal.stm and [Abstract] http://grande.nal.usda.gov/ibids/index.php?mode2=detail&origin=ibids_references&therow=763366
35. Fleischer, D. M., M. K. Conover-Walker, et al. (2004). "Peanut allergy: recurrence and its management." J Allergy Clin Immunol 114(5): 1195-201. [PubMed Abstract]
36. Brandtzaeg, P. E. (2002). "Current understanding of gastrointestinal immunoregulation and its relation to food allergy." Ann N Y Acad Sci 964: 13-45. [Full Text] http://www.annalsnyas.org/cgi/content/full/964/1/13
37. Turcanu, V., S. J. Maleki, et al. (2003). "Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts." J Clin Invest 111(7): 1065-72. [Full Text] http://www.jci.org/cgi/content/full/111/7/1065
38. Braun, C. M., S. K. Huang, et al. (1997). "Corticosteroid modulation of human, antigenspecific Th1 and Th2 responses." J Allergy Clin Immunol 100(3): 400-7. [PubMed Abstract]
39. Dhiman, N., I. G. Ovsyannikova, et al. (2005). "Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination." Clin Exp Immunol 142(3): 498-504. [Full Text] http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16297162
40. Cozen, W., D. Diaz-Sanchez, et al. (2004). "Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption." J Clin Immunol 24(6): 617-22. [PubMed Abstract]
41. Becker, Y. (2006). "Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review." Virus Genes 33(2): 235-52. [PubMed Abstract]
42. van Zijverden, M., A. van der Pijl, et al. (2000). "Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity." Toxicol Appl Pharmacol 168(2): 131-9. [PubMed Abstract]
43. Turcanu, V., S. J. Maleki, et al. (2003). "Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts." J Clin Invest 111(7): 1065-72. [Full Text] http://www.jci.org/cgi/content/full/111/7/1065
44. Turcanu, V., S. J. Maleki, et al. (2003). "Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts." J Clin Invest 111(7): 1065-72. [Full Text] http://www.jci.org/cgi/content/full/111/7/1065
45. Thottingal, T. B., B. P. Stefura, et al. (2006). "Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression." J Allergy Clin Immunol 118(4): 905-14. [PbuMed Abstract]
46. Ring, J. and M. Mohrenschlager (2007). "Allergy to peanut oil--clinically relevant?" J Eur Acad Dermatol Venereol 21(4): 452-5. [PubMed Abstract]
47. Dixon, V., S. Habeeb, et al. (2007). "Did you know this medicine has peanut butter in it, doctor?" Arch Dis Child 92(7): 654. [Abstract] http://allallergy.net/abstracts/index.cfm?ShowMonth=August2007
48. Codreanu, F., M. Morisset, et al. (2006). "Risk of allergy to food proteins in topical medicinal agents and cosmetics." Allerg Immunol (Paris) 38(4): 126-30. [PubMed Abstract]
49. Positively Aging, (2004) Why Opposites Attract: Blood Agglutination. The University of Texas Health Science Center at San Antonio [Full Text] http://teachhealthk-12.uthscsa.edu/curriculum/blood/blood03b.htm and http://teachhealthk-12.uthscsa.edu/curriculum/blood/blood-pdf/blood-03b-tho-opposites.pdf
50. Haines, D. M. (1993). "Peanut agglutinin lectin immunohistochemical staining of normal and neoplastic canine tissues." Vet Pathol 30(4): 333-42. [PubMed Abstract]
51. Newman, R. A. and M. A. Boss (1980). "Expression of binding sites for peanut agglutinin during murine B lymphocyte differentiation." Immunology 40(2): 193-200. [Full Text] http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=6997192
52. Moorghen, M. and F. Carpenter (1991). "Peanut lectin: a histochemical marker for phaeochromocytomas." Virchows Arch A Pathol Anat Histopathol 419(3): 203-7. [PubMed Abstract]
53. Obi, C. L., A. A. Olubunmi, et al. (1998). "Diagnostic potentials of the activities of lectins with whole cells of three bacterial diarrheagenic agents: Aeromonas, Plesiomonas, Campylobacter." Afr J Health Sci 5(1-2): 96-9. [PubMed Abstract]
54. Xiang, S. L., M. Zhong, et al. (2006). "The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barre syndrome." J Neuroimmunol 174(1-2): 126-32.
55. Mocchetti I (2005). "Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins". Cell Mol Life Sci 62 (19-20): 2283-94. PMID 1615819
56. Perera, V. N., I. Nachamkin, et al. (2007). "Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies." FEMS Immunol Med Microbiol 50(1): 27-36. [PubMed Abstract]
57. Yu, R. K., S. Usuki, et al. (2006). "Ganglioside molecular mimicry and its pathological roles in Guillain-Barre syndrome and related diseases." Infect Immun 74(12): 6517-27. [Full Text] http://iai.asm.org/cgi/content/full/74/12/6517?view=long&pmid=16966405
58. Kielczynski, W., L. C. Harrison, et al. (1991). "Direct evidence that ganglioside is an integral component of the thyrotropin receptor." Proc Natl Acad Sci U S A 88(5): 1991-5. [Full Text] http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2000404
59. Bersudsky, M., P. Rosenberg, et al. (2000). "Lipopolysaccharides of a Campylobacter coli isolate from a patient with Guillain-Barre syndrome display ganglioside mimicry." Neuromuscul Disord 10(3): 182-6. [PubMed Abstract]
60. Hageman, G. S. and L. V. Johnson (1986). "Biochemical characterization of the major peanut-agglutinin-binding glycoproteins in vertebrate retinae." J Comp Neurol 249(4): 499-510, 482-3. [PubMed Abstract]
61. Maguire, L. S., S. M. O'Sullivan, et al. (2004). "Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut." Int J Food Sci Nutr 55(3): 171-8. [PubMed Abstract]
62. Khanna, D., G. Sethi, et al. (2007). "Natural products as a gold mine for arthritis treatment." Curr Opin Pharmacol 7(3): 344-51. [PubMed Abstract]
63. Shakibaei, M., T. John, et al. (2007). "Resveratrol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro." Ann N Y Acad Sci 1095: 554-63. [PubMed Abstract]
64. Sareen, D., S. R. Darjatmoko, et al. (2007). "Mitochondria, Calcium, and Calpain are Key Mediators of Resveratrol-Induced Apoptosis in Breast Cancer." Mol Pharmacol. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17848600
65. Tay, S. S., A. T. Clark, et al. (2007). "Patterns of immunoglobulin G responses to egg and peanut allergens are distinct: ovalbumin-specific immunoglobulin responses are ubiquitous, but peanut-specific immunoglobulin responses are up-regulated in peanut allergy." Clin Exp Allergy 37(10): 1512-8. [PubMed Abstract]
66. Dodo, H. W., K. N. Konan, et al. (2007). "Alleviating peanut allergy using genetic engineering: the silencing of the immunodominant allergen Ara h 2 leads to its significant reduction and a decrease in peanut allergenicity." Plant Biotechnol J. [PubMed Abstract]
67. Wassenberg, J. and M. Hofer (2007). "Lupine-induced anaphylaxis in a child without known food allergy." Ann Allergy Asthma Immunol 98(6): 589-90. [PubMed Abstract]
68. Reis, A., N. Fernandes, et al. (2007). "Lupin sensitisation in a population of 1,160 subjects." Allergol Immunopathol (Madr ) Jul 1;35(4):162-163.
69. Peeters, K. A., J. A. Nordlee, et al. (2007). "Lupine allergy: not simply cross-reactivity with peanut or soy." J Allergy Clin Immunol 120(3): 647-53. [PubMed Abstract]
70. de Groot, H. (2007). "[Allergy to cashew nuts and peanuts]." Ned Tijdschr Geneeskd 151(18): 997-1001. [PubMed Abstract]
71. Clark, A. T., K. Anagnostou, et al. (2007). "Cashew nut causes more severe reactions than peanut: case-matched comparison in 141 children." Allergy 62(8): 913-6. [PubMed Abstract]
72. Rolland, J. M., E. Apostolou, et al. (2006). "Potential food allergens in wine: Double-blind, placebo-controlled trial and basophil activation analysis." Nutrition 22(9): 882-8. [PubMed Abstract]
73. Mittag, D., J. Akkerdaas, et al. (2004). "Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy." J Allergy Clin Immunol 114(6): 1410-7. [PubMed Abstract]
74. Glaspole, I. N., M. P. de Leon, et al. (2007). "Anaphylaxis to lemon soap: citrus seed and peanut allergen cross-reactivity." Ann Allergy Asthma Immunol 98(3): 286-9. [PubMed Abstract]
75. Bottner, M., J. Christoffel, et al. (2006). "Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on the pituitary-thyroid-axis." Exp Clin Endocrinol Diabetes 114(2): 82-90. [PubMed Abstract]
76. Jiang, R., J. E. Manson, et al. (2002). "Nut and peanut butter consumption and risk of type 2 diabetes in women." Jama 288(20): 2554-60. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12444862
77. Dalal, I., I. Binson, et al. (2003). "The pattern of sesame sensitivity among infants and children." Pediatr Allergy Immunol 14(4): 312-6. [PubMed Abstract]
78. Beausoleil, J. L. and J. M. Spergel (2006). "Late diagnosis of tree nut and sesame allergy in patients previously sensitized but tolerant to peanut." Ann Allergy Asthma Immunol 97(4): 443-5. [PubMed Abstract]
79. Teuber, S. S. (2002). "Hypothesis: the protein body effect and other aspects of food matrix effects." Ann N Y Acad Sci 964: 111-6. [PubMed Abstract]
80. Hefle, S. L., T. J. Furlong, et al. (2007). "Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts." J Allergy Clin Immunol 120(1): 171-6. [PubMed Abstract]
81. Pereira, M. J., M. T. Belver, et al. (2002). "[The allergenic significance of legumes]." Allergol Immunopathol (Madr) 30(6): 346-53. [PubMed Abstract]
82. Nontprasert, A., S. Pukrittayakamee, et al. (2000). "Studies of the neurotoxicity of oral artemisinin derivatives in mice." Am J Trop Med Hyg 62(3): 409-12. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11037787
83. Franquemont, D. W., S. E. Mills, et al. (1994). "Immunohistochemical detection of neuroblastomatous foci in composite adrenal pheochromocytoma-neuroblastoma." Am J Clin Pathol 102(2): 163-70. [PubMed Abstract]
84. Murray, J. L., K. C. Loftin, et al. (1985). "Elevated adenosine deaminase and purine nucleoside phosphorylase activity in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome." Blood 65(6): 1318-24. [PubMed Abstract]
85. Norioka, S., K. Omichi, et al. (1982). "Purification and characterization of protease inhibitors from peanuts (Arachis hypogaea)." J Biochem (Tokyo) 91(4): 1427-34. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7096296
86. Gennis, L. S. (1976). "Double-headed protease inhibitors from black-eyed peas. V. Analysis of the energetics of protease-inhibitor interactions." J Biol Chem 251(3): 763-8. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1249052 87. Parakash, B., Selvaraj, S., Murthy, M. R. N., Sreerama, Y. N., Rao, D. R., and Gowda, L. R. Analysis of the amino acid sequences of plant Bowman-Birk inhibitors. J. Mol. Evol., 42: 560–569, 1996. 88. Lippman, S. M. and L. M. Matrisian (2000). "Protease inhibitors in oral carcinogenesis and chemoprevention." Clin Cancer Res 6(12): 4599-603. [Full Text] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11156207 89. Jacobs, J. L., T. L. Carroll, et al. (2005). "The role of pigmentation, ultraviolet radiation tolerance, and leaf colonization strategies in the epiphytic survival of phyllosphere bacteria." Microb Ecol 49(1): 104-13. [PubMed Abstract] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15883865 90. Kennedy, A. R., Z. Zhou, et al. (2006). "Protection against adverse biological effects induced by space radiation by the Bowman-Birk inhibitor and antioxidants." Radiat Res 166(2): 327-32.[Abstract] http://www.bioone.org/perlserv/?request=get-pdf&doi=10.1667%2FRR3599.1
